Lymphatic system component

Similar documents
Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s

LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital

Understanding your diagnosis. Dr Graham Collins Consultant Haemtologist Oxford University Hospitals

Lymphoma: The Basics. Dr. Douglas Stewart

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

Lymphoma is a cancer that develops in the white blood cells (lymphocytes) of the lymphatic system, which is part of the body's immune system.

NON- HODGKIN LYMPHOMA

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

Indolent Lymphomas. Dr. Melissa Toupin The Ottawa Hospital


Indolent Lymphomas: Current. Dr. Laurie Sehn

Hodgkin's Lymphoma. Symptoms. Types

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University

Lymphoma: What You Need to Know

7.342 Chronic infection and inflammation: What are the consequences on your health? Instructors Eva Frickel and Sara Gredmark

Acute Lymphocytic Leukemia Early Detection, Diagnosis, and Types

Overview of Cutaneous Lymphomas: Diagnosis and Staging. Lauren C. Pinter-Brown MD, FACP Health Sciences Professor of Medicine and Dermatology

During past decades, because of the lack of knowledge

LYMPHOMAS an overview of some subtypes of NHLs

Non-Hodgkin lymphoma

WHO Classification. B-cell chronic lymphocytic leukemia/small T-cell granular lymphocytic leukemia

Aggressive Lymphomas - Current. Dr Kevin Imrie Physician-in-Chief, Sunnybrook Health Sciences Centre

Lymphoid Neoplasms. Sylvie Freeman Department of Clinical Immunology, University of Birmingham

Non-Hodgkin Lymphoma. Protocol applies to non-hodgkin lymphoma involving any organ system except the gastrointestinal tract.

Non-Hodgkin Lymphoma Early Detection, Diagnosis, and Staging

Lymphoma and Myeloma Kris3ne Kra4s, M.D.

Chronic Lymphocytic Leukemia Early Detection, Diagnosis, and Staging

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e

Blood Cancer: Chronic Myelogenous Leukaemia

Hodgkin Disease Early Detection, Diagnosis, and Staging

HODGKIN DISEASE. What is cancer?

Classifications of lymphomas

Lymphoma (Lymphosarcoma) by Pamela A. Davol

Lymphoma of the Skin Early Detection, Diagnosis, and Staging

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

Pathology of Hematopoietic and Lymphoid tissue

Monsanto s Spin on its Roundup herbicide is Unwinding

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes

2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes

Abstracting Hematopoietic Neoplasms

Pathology of Hematopoietic and Lymphoid tissue

Harmesh Naik, MD. GME Presentation to Family Practice Residents October 16, 2013.

ACHIEVING EXCELLENCE IN ABSTRACTING: LYMPHOMA

2012 by American Society of Hematology

Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU

HIV and Malignancy Alaka Deshpande, Himanshu Soni

88-year-old Female with Lymphadenopathy. Faizi Ali, MD

NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary)

LYMPHOMA DIAGNOSIS and PROGNOSIS. LC Lim Dept of Hematology Singapore General Hospital

FOLLICULARITY in LYMPHOMA

Childhood Leukemia Early Detection, Diagnosis, and Types

Morton Coleman, MD, NewYork-Presbyterian Hospital/Weill Cornell Medical College

Chronic Lymphocytic Leukemia (CLL)

Change Summary - Form 2018 (R3) 1 of 12

Cancer , The Patient Education Institute, Inc. ocf80101 Last reviewed: 06/08/2016 1

NAACCR Webinar Series 1

Lymphoma Read with the experts

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

CELL-MEDIATED IMMUNITY

Q&A Session Collecting Cancer Data: Hematopoietic and Lymphoid Neoplasms Thursday, November 6, 2014

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

GAZYVA: for follicular lymphoma that has not responded to or has returned after treatment

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Parts 2 and 3

Update in Lymphoma Imaging

The Lymphomas. An overview..

NON HODGKINS LYMPHOMA: AGGRESSIVE Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary)

Immunopathology of Lymphoma

Small B-cell (Histologically Low Grade) Lymphoma

LYMPHOPROLIFERATIVE DISORDERS. Dr Mere Kende MBBS, MMED (Path), MACTM, MACRRM, MAACB Lecturer: SMHS, UPNG

CHRONIC LYMPHOCYTIC LEUKEMIA

Plasma cell myeloma (multiple myeloma)

Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113)

Neoplastic proliferation arising from white blood cells. Introductory remarks. Classification

The Lymphatic System

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Clinical Policy: Bendamustine (Bendeka, Treanda) Reference Number: PA.CP.PHAR.307

Infections and nonmicrobial inflammatory stimuli can cause leukocytosis (as seen in Lab 1) as well as lymph node enlargement (lymphadenopathy).

Low grade High grade , immune suppression chronic persistent inflammation viruses B-symptoms

Latest Press Release. Celexa italiano

The Lymphatic System

CLINICAL MEDICAL POLICY

Understanding Lymphoma

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

Case 3. Ann T. Moriarty,MD

Lymphatic System Disorders

Cancer 101 Spring Family Cancer Retreat 4/18/15. Amish Shah, M.D. New Mexico Cancer Center

Different Types of Cancer

Low-grade non-hodgkin lymphoma

BIT 120. Copy of Cancer/HIV Lecture

What is Thyroid Cancer? Here are four types of thyroid cancer:

Contents. vii. Preface... Acknowledgments... v xiii

Integrated Hematopathology. Morphology and FCI with IHC

Cancer. University of Illinois at Chicago College of Nursing

Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation

Esophageal cancer. What is esophageal cancer? Esophageal cancer is a disease in which malignant (cancer) cells form in the tissues of the esophagus.

Transcription:

Introduction Lymphatic system component Statistics Overview Lymphoma Non Hodgkin s Lymphoma Non- Hodgkin's is a type of cancer that originates in the lymphatic system. It is estimated to be the sixth most common cancer in the United States. Lymph vessels These vessels branch out throughout the body similar to blood vessels The lymph vessels carry a clear fluid called lymph. Lymph contains white blood Lymph cells, especially lymphocytes such as B cells and T cells Lymph vessels are interconnected to small masses of lymph tissue called lymph nodes. Lymph nodes Lymph nodes are found throughout the body. Collections of lymph nodes are found in the neck, underarms(axillae), chest, abdomen, and groin. Lymph nodes store white blood cells. When you are ill and the lymph nodes are active, they will swell and be easily palpable Additional The tonsils, thymus, and spleen are additional components of the lymphatic parts of the system. Lymphatic tissue is also found in other parts of the body, including lymphatic the stomach, skin, and small intestine. system Because lymphatic tissue is found in many parts of the body, non- Hodgkin's can start almost anywhere nb The lymphatic system is part of the body's immune system and helps fight infections and other diseases. In addition, the lymphatic system filters out bacteria, viruses, and other unwanted substances. 6th most common cause of cancer death in United States. Increasing in incidence and mortality. Since 1970, the incidence of has almost doubled. Estimated new cases and deaths from non- Hodgkin in the United States in 2014: New cases: 70,800, Deaths: 18,990 The types of non- Hodgkin s reflect the developmental stages of lymphocytes. Each type of can be viewed as a lymphocyte arrested at a certain stage of development and transformed into a malignant cell. 85% B cell origin, the rest T or null cell

How is NHL staging determined? Pathophysiology Cells involved Risk factors 1. Bone marrow biopsy 2. CT scan 3. MRI 4. Ultrasound 5. PET scan: Radioactive material is injected, and a CT scan is performed to determine the metabolism of this material. Lymphoma cells show faster metabolism than normal cells, and areas with look brighter on the pictures Non- Hodgkin's (NHL). NHL occurs when your body produces too many abnormal lymphocytes. In the normal life cycle of lymphocytes, old lymphocytes die and your body creates new ones to replenish the supply. In NHL, lymphocytes grow indefinitely, so the number of circulating lymphocytes increases, filling up the lymph nodes and causing them to swell. In NHL, either B cells or T cells are involved in this process. These are the two subtypes of lymphocytes. B cells produce antibodies that fight infections. This is the most common type of cell involved in NHL. T cells kill the foreign substances directly. NHL less frequently originates from T cells. 1. Medications that suppress your immune system: Using immunosuppressive agents (such as after an organ transplant) is a risk factor as it reduces your body ability to fight infection. 2. Weakened immune system: The risk of developing may be increased by having a weakened immune system. 3. Certain infections: Certain viral and bacterial infections increase the risk of NHL. Examples are HIV, hepatitis C virus, and Epstein- Barr virus. A type of bacteria sometimes linked to NHL is the ulcer- causing H. pylori. Note: Lymphoma is not contagious. You cannot catch from another person.

Etiology Epidemiology Clinical feature Diagnosis of NHL Immune suppression DNA repair defects Chronic inflammation and antigenic stimulation 1. Congenital (Wiskott- Aldrich) 2. Organ transplant (cyclosporine) 3. AIDS 4. Increasing age 1. Ataxia telangiectasia 2. Xeroderma pigmentosum 1. Helicobacter pylori inflammation, stomach 2. Chlamydia psittaci inflammation, ocular adnexal tissues 3. Sjögren s syndrome 1. EBV and Burkitt s Viral causes 2. HTLV- I and T cell leukemia- 3. HTLV- V and cutaneous T cell 4. Hepatitis C Although non- Hodgkin's can occur in young people, the chance of Age developing this disease increases with age. Most people with non- Hodgkin's are older than 60 years of age. People who work with herbicides or certain other chemicals may be at Other possible increased risk of this disease. links Researchers are also looking at a possible link between using hair dyes before 1980 and non- Hodgkin's. None of these possible links have definitely been proven. Note: Having one or more risk factors does not mean that a person will develop non- Hodgkin's. Can occur at any age Overall incidence, and incidence of subtypes, varies with location: Burkitt s in tropical Africa Adult T cell leukemia- in Japan and Caribbean Indolent s are rare in young people and increase in incidence with age. Large cell (DHL) is less age related, and is among most common cancers affecting the young. Burkitt s and lymphoblastic are common in adolescents. AIDS patients develop aggressive, high grade s. 1. Lymphadenopathy 2. Cytopenias 3. Systemic symptoms 4. Hepatosplenomegaly 5. Fever 6. Night sweats Lymphadenopathy may fluctuate or spontaneously remit, especially in low- grade s. B symptoms more common in high- grade s. Hematogenous spread of disease, with no predictable pattern. Classic : arises in lymph node or bone marrow. Extranodal primary more common in high- grade. Waldeyer s ring involvement frequent in GI s. Signs and symptoms 1. Swollen, painless lymph nodes in the neck, armpits, or groin 2. Unexplained weight loss 3. Fever 4. Night sweats 5. Coughing, trouble breathing, or chest pain 6. Weakness and tiredness that don't go away (fatigue) 7. Abdominal pain or swelling, or a feeling of fullness in the abdomen 8. Itching of the skin Excisional biopsy is preferred to show nodal architecture (follicular vs diffuse). Immunohistochemistry to confirm cells are lymphoid Ø LCA (leukocyte common antigen) Ø Monoclonal staining with Igk or Igl Flow cytometry: Ø CD 19, CD20 for B cell s Ø CD 3, CD 4, CD8 for T cell s Chromosome changes Ø 14;18 translocation in follicular à bcl- 2 oncogene Ø t(8;14), t(2;8), t(8;22) in Burkitt s à c- myc oncogene Ø t(11;14) in mantle cell à cyclin D1 gene

How is NHL diagnosed? Staging workup Staging: Ann Arbor Physical exam Medical history Blood tests Imaging procedures Biopsy Bone marrow biopsy o o o Your doctor will complete a physical examination with a special emphasis on palpating your lymph nodes in your neck, underarms, and groin and establishing if they are swollen. He will also try to find out if your spleen or liver are swollen. In most cases, swollen lymph nodes are signs of infection (rather than ), and your doctor will try to establish if you have any other signs of infection and what the source of the infection could be. You will be asked questions in regards to your past medical history and about risk factors for NHL. A complete blood count (CBC) will usually be performed to check the number of white blood cells. Additional tests might include a lactate dehydrogenase level (can be elevated in ). Additional tests might be performed to rule out an infection causing the swollen lymph nodes. o A chest X- ray or CT scan of the chest or neck might help detect the presence of tumors or more enlarged lymph nodes. Positron emission tomography (PET) scanning is a newer modality to help detect NHL. o Biopsy of lymph nodes to diagnose the cause of the swelling. The samples will then be given to a pathologist who will review the sample under the microscope and establish a diagnosis. o There are three ways to diagnose a lymph node: 1. removal of the entire lymph node (excisional biopsy); 2. partial removal of a lymph node (incisional biopsy); 3. fine- needle aspiration (using a thin needle to remove some lymph node tissue) is often not diagnostic as not enough tissue is removed for the pathologist to make a diagnosis. A bone marrow biopsy can establish the spread of the disease. This involves the insertion of a needle into bone to obtain bone marrow. In adults, the most common site for this biopsy is the pelvic bone CBC, chemistries, urinanalysis CT scans of chest, abdomen and pelvis Bone marrow biopsy and aspirate (Lumbar puncture) AIDS T cell lymphoblastic High grade with positive marrow Stage I Stage II The cells are found in only one lymph node area (such as in the neck or axilla). Or, if the abnormal cells are not in the lymph nodes, they are in only one part of a tissue or organ (such as the lung, but not the liver or bone marrow). The cells are found in at least two lymph node areas on the same side of the body or only above or below the diaphragm. Or the cells are in one organ and the lymph nodes affected are near that organ Stage III The is in lymph nodes above and below the diaphragm. There might be spread into an organ near this lymph node group. Stage IV In addition to lymph cell spread, cells are found in several parts of one or more organs or tissues. A No symptoms (You have not had weight loss, fever or night sweats) B Presence of any of the following symptoms: weight loss (10 % or more in the last six months), fever (greater than 101.5 F) night sweats, or severe itching I 1 lymph node region or structure II >1 lymph node region or structure, same side of diaphragm III Both sides of diaphragm IV Extranodal sites beyond E designation subssripts: A, B, E, S

Types of Commonly used classification The REAL Classification (Revised European- American Lymphoma Classification) Common subtypes of NHL nb Classification of Non Hodgkin Lymphoma Indolent (low grade) Intermediate Aggressive (high grade) 1. Life expectancy in years, untreated 2. 85-90% present in Stage III or IV 3. Incurable Working formulae Small lymphocytic Low Grade Intermediate Grade Follicular small cleaved Follicular mixed Follicular large cell Diffuse small cleaved cell Diffuse mixed Diffuse large cell 1. Life expectancy in weeks, untreated 2. Potentially curable Rappaport Diffuse well- differentiated lymphocytic (DWDL or WDLL) Nodular poorly differentiated lymphocytic (NPDL) Nodular mixed lymphocytic- histiocytic (NM) Nodular histiocytic (NH) Diffuse poorly differentiated lymphocytic (DPDL) Diffuse mixed lymphocytic- histiocytic (DM) Diffuse histiocytic (DHL) Large cell immunoblastic Diffuse histiocytic (DHL) High Grade Lymphoblastic Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s Diffuse undifferentiated (DU) Not included in these classification Mycosis fungoides Marginal zone B cell à MALT Mantle cell Peripheral T cell Angioimmunoblastic 1. Precursor B- lymphoblastic /leukemia 13. Primary mediastinal large B cell 2. B cell CLL/prolymphocytic leukemia/small 14. Burkitt s lymphocytic leukemia 15. High grade B cell, Burkitt- like 3. Lymphoplasmacytoid 16. Precursor T lymphoblastic /leukemia 4. Mantle cell 17. T cell CLL/prolymphocytic leukemia 5. Follicular center, follicular 18. Large cell granular lymphocytic leukemia: T cell 6. Follicular center, diffuse type, NK cell type 7. Extranodal marginal zone B cell (MALT 19. Mycosis fungoides/ Sézary syndrome type) 20. Peripheral T cell s, unspecified 8. Nodal marginal zone B cell 21. Hepatosplenic T cell 9. Splenic marginal zone B- cell 22. Angioimmunoblastic T cell 10. Hairy cell leukemia 11. Plasmacytoma/myeloma 12. Diffuse large B cell Burkitt Diffuse large cell Follicular This has two major subtypes, an African type closely associated with an infection with the Epstein- Barr virus and the non- African, or sporadic, form that is not linked to the virus. This represents the most common (approximately 30% of NHL) and can be rapidly fatal if not treated. These s exhibit a specific growth pattern when viewed under the microscope (follicular or nodular pattern); they are usually advanced at the time of diagnosis. MALT This is a B cell that usually affects individuals in their 60s. The most common area for this to develop is the stomach. One of the rarest of the NHL, mantle cell accounts for about 6% of cases. This NHL is difficult to treat and is a subtype of B cell. Mantle cell Adult T cell /leukemia: This is a rare but aggressive NHL of the immune system's T cells. Human T cell leukemia/lymphotropic virus type (HTLV- 1) is believed to be the cause The guidelines also say that a GP should investigate and possibly refer anyone with combinations of the following symptoms Tiredness (fatigue) Weight loss High temperature (fever) Night sweats Itching Being short of breath Bruising easily or bleeding Having infections that keep coming back Bone pain or nerve pain Abdominal pain An enlarged spleen or lymph nodes